凝血功能监测在慢加急性肝衰竭诊治中的相关研究进展

摘要/Abstract

摘要： 慢加急性肝衰竭(ACLF)是目前肝衰竭中最常见的一类,病情进展迅速,短期预后差,凝血功能障碍是其最显著的特征之一。凝血障碍的处理是临床治疗中的关键环节之一,因而从ACLF疾病特征及发病机制着手,就凝血功能的监测与疾病诊治进展作一综述,以期在疾病进展过程中及时治疗,对于疾病转归、改善患者生存具有重要临床意义。

关键词: 慢加急性肝功能衰竭, 凝血功能, INR, 血栓弹力图

李雪, 张亮, 王枭, 易海, 汤善宏. 凝血功能监测在慢加急性肝衰竭诊治中的相关研究进展[J]. 肝脏, 2023, 28(2): 247-249.

[1] Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int, 2019, 13(4):353-390.
[2] Valla DC, Rautou PE. The coagulation system in patients with end-stage liver disease. Liver Int,2015,35:139-144.
[3] 刘磊,郑山根. 血栓弹力图监测肝衰竭患者凝血功能的临床研究进展. 解放军预防医学杂志,2019,03:187-189.
[4] Mezzano G, Juanola A, Cardenas A, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut,2022, 71(1):148-155.
[5] Piano S, Bartoletti M, Tonon M, et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut,2018, 67(10):1892-1899.
[6] Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut, 2018, 67(10):1870-1880.
[7] Qi T, Zhu C, Lu G, Hao J, et al. Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China: a retrospective study. BMC Gastroenterol,2019, 19(1):20.
[8] Li H, Chen LY, Zhang NN, et al. Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B. Sci Rep ,2016,6:25487.
[9] Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut, 2018, 67(12):2181-2191.
[10] Premkumar M, Saxena P, Rangegowda D, et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int,2019, 39(4):694-704.
[11] 曾艳丽,高飞,魏君峰,等. 血栓弹力图评价慢加急性肝衰竭患者的凝血功能及预后研究. 中华肝脏病杂志,2017,01:32-37.
[12] Fisher C, Patel VC, Stoy SH, et al. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care,2018, 43:54-60.
[13] 蒋雯,郑泽美,李军. 凝血、纤溶与抗凝指标在慢性肝衰竭患者中的变化及相关性. 检验医学与临床,2019,22:3340-3343.
[14] Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol,2017, 23(18):3228-3239.
[15] Saab S, Brown RS Jr. Management of thrombocytopenia in patients with chronic liver disease. Dig Dis Sci,2019, 64(10):2757-2768.
[16] Stravitz RT, Ellerbe C, Durkalski V, et al. Bleeding complications in acute liver failure. Hepatology,2018, 67(5):1931-1942.
[17] Lesurtel M, Clavien PA. Platelet-derived serotonin: translational implications for liver regeneration. Hepatology,2014, 60(1):30-33.
[18] Jie Y, Gong J, Xiao C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure. Biomed Res Int, 2018:7394904.
[19] Aryal B, Yamakuchi M, Shimizu T, et al. Therapeutic implication of platelets in liver regeneration -hopes and hues. Expert Rev Gastroenterol Hepatol, 2018,12(12):1219-1228.
[20] 孙京华,卢发强. D-二聚体在临床应用中的新进展. 世界最新医学信息文摘,2019,82:98-99.
[21] 窦芊,杜敬佩,赵巍峰. 凝血及抗凝血指标监测对各型肝病的临床意义. 中西医结合肝病杂志,2016,04:237-238.
[22] Fang P, Du L, Cai D. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore),2020, 99(12):e19461.
[23] Allison MG, Shanholtz CB, Sachdeva A. Hematological issues in liver disease. Crit Care Clin,2016, 32(3):385-396.
[24] 吕滨月,李谦. 肝衰竭患者的出凝血状态评估策略. 临床肝胆病杂志,2020,04:928-931.
[25] Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev,2012, 26(1):1-13.
[26] 杨敬端. 血栓弹力图检测对慢加急性肝衰竭患者凝血功能及预后评估的价值. 中国民康医学,2020,18:92-95.
[27] 郑洁莹,罗文波,吴为强. 血栓弹力图与传统凝血试验对肝病凝血功能评价的相关性研究. 基层医学论坛,2021,25:3658-3660.
[28] De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology,2016, 63(2):566-573.
[29] 袁宏香,张秋云,娄金丽,等. 慢加急性肝衰竭血小板减少患者血栓弹力图及常规凝血指标的变化. 肝脏,2020,01:20-23.
[30] Bedreli S, Sowa JP, Gerken G, et al. Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis. Gut,2016, 65(2): 357-358.
[31] Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration. Blood,2016, 128(5):625-629.
[32] Xu X, Hou Z, Xu Y, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol, 2021 ,45(2):101482.
[33] Han L, Han T, Nie C, et al. Elevated mean platelet volume is associated with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol, 2015, 39(3):331-339.
[34] 李剀. 血浆置换联合双重血浆分子吸附系统对慢加急性肝衰竭患者炎性水平及凝血指标的影响分析. 现代诊断与治疗,2021,11:1683-1685.

凝血功能监测在慢加急性肝衰竭诊治中的相关研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	袁小莉, 王德琴, 徐晓英. 血浆置换术联合低分子肝素钠对妊娠期急性脂肪肝患者凝血和肝肾功能及妊娠结局的影响[J]. 肝脏, 2023, 28(2): 238-241.
[2]	莫瑞东, 章正兰, 殷荣坤, 周艳梅, 王月, 尹朋博, 张辰溪, 付豪爽, 钱聪, 项晓刚, 谢青. 肥胖对HBV相关慢加急性肝衰竭和失代偿性肝硬化患者疾病严重程度和短期预后的影响[J]. 肝脏, 2022, 27(7): 742-747.
[3]	王俊峰, 赵亮, 王俊杰, 杨春秋. 脓毒血症肝损伤患者血清TBA、ALP水平与凝血功能特征观察[J]. 肝脏, 2022, 27(5): 593-595.
[4]	张贝克, 范永刚, 张莹楠, 解刚强. 创伤性肝损伤患者活化蛋白C水平与凝血功能及预后的相关性[J]. 肝脏, 2022, 27(2): 233-237.
[5]	吕莹, 蒋式骊, 吕靖, 赵长青, 邢枫, 顾宏图, 袁继丽, 刘成海, 刘平, 慕永平. 肝硬化食管静脉曲张程度与实验室检测指标的相关性分析[J]. 肝脏, 2022, 27(10): 1096-1101.
[6]	宦红娣. 肝硬化患者中急性肾损伤的代谢组学研究[J]. 肝脏, 2022, 27(1): 15-16.
[7]	郑爱梅, 张四芳, 刘晓燕, 郑丽. 低分子肝素钠联合腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的疗效及对母婴结局的影响[J]. 肝脏, 2020, 25(12): 1337-1339.
[8]	江丽萍, 陈阮琴, 陈明胜. 纤维蛋白原是影响HBV相关慢加急性肝衰竭近期预后的独立危险因素[J]. 肝脏, 2020, 25(10): 1090-1093.
[9]	袁宏香, 张秋云, 娄金丽, 于艳华, 赵艳. 慢加急性肝衰竭血小板减少患者血栓弹力图及常规凝血指标的变化[J]. 肝脏, 2020, 25(1): 20-23.
[10]	范红顺, 熊志娇, 马超, 邱少霞, 沈莉华. 小剂量激素辅助双重血浆分子吸附治疗早期慢加急性肝功能衰竭的疗效及抗SLA水平观察[J]. 肝脏, 2019, 24(7): 770-773.
[11]	李永芳, 李娟, 吴慧慧, 蔡伟, 刘芸野. 胸腺肽α1对乙型肝炎相关慢加急性肝衰竭疗效分析[J]. 肝脏, 2019, 24(6): 677-679.
[12]	周凡, 王冉. 慢加急性乙型肝炎肝衰竭患者血清OPN和IFI 16水平变化及临床意义[J]. 肝脏, 2019, 24(5): 534-537.
[13]	李敏, 胡文静. 不同种类血浆在慢性重型肝炎患者血浆置换的评价疗效[J]. 肝脏, 2019, 24(2): 160-162.
[14]	姚立鹏, 闫晓虹, 徐萍, 胡建利, 林飞蕾, 陈杨杨. 核苷和核苷酸类似物治疗乙型肝炎相关慢加急性肝衰竭近期预后多因素分析[J]. 肝脏, 2018, 23(1): 40-43.
[15]	李妍,杨宁,洪炜,王晗. 乙型肝炎相关肝功能衰竭继发感染的实验室指标变化特点研究[J]. 肝脏, 2017, 22(7): 613-616.